Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts

$18.08

-0.35 (-1.90%)

(As of 09/6/2024 ET)

Upcoming Earnings Date: Nov. 13Estimated
Actual EPS (Jul. 31): $0.58 Beat By $0.03
Consensus EPS (Jul. 31): $0.55

TEVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TEVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Behind the Markets

⭕ [URGENT] Buy Alert just triggered

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

Teva Pharmaceutical Industries Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	$0.48	$0.48	$0.48
Q2 2024	1	$0.56	$0.56	$0.56
Q3 2024	1	$0.57	$0.57	$0.57
Q4 2024	1	$0.67	$0.67	$0.67
FY 2024	4	$2.28	$2.28	$2.28
Q1 2025	1	$0.44	$0.44	$0.44
Q2 2025	1	$0.58	$0.58	$0.58
Q3 2025	1	$0.66	$0.66	$0.66
Q4 2025	1	$0.83	$0.83	$0.83
FY 2025	4	$2.51	$2.51	$2.51
Q1 2026	1	$0.50	$0.50	$0.50
Q2 2026	1	$0.64	$0.64	$0.64

TEVA Earnings Date and Information

Teva Pharmaceutical Industries last announced its earnings data on July 31st, 2024. The reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.03. The company earned $4.16 billion during the quarter, compared to analysts' expectations of $3.99 billion. Teva Pharmaceutical Industries has generated ($0.41) earnings per share over the last year (($0.41) diluted earnings per share). Earnings for Teva Pharmaceutical Industries are expected to grow by 11.91% in the coming year, from $2.35 to $2.63 per share. Teva Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off prior year's report dates.

Teva Pharmaceutical Industries Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/13/2024 (Estimated)	-	-	-	-	-	-	-
7/31/2024	Q2 2024	$0.55	$0.58	+$0.03	$1.91	$3.99 billion	$4.16 billion
5/8/2024	Q1 2024	$0.49	$0.46	($0.03)	$1.04	$3.70 billion	$3.82 billion
1/31/2024	Q4 2023	$0.73	$0.98	+$0.25	$1.55	$3.97 billion	$4.46 billion
11/8/2023	Q3 2023	$0.57	$0.60	+$0.03	$1.09	$3.73 billion	$3.90 billion
8/2/2023	Q2 2023	$0.52	$0.54	+$0.02	$1.85	$3.69 billion	$3.88 billion
5/10/2023	Q1 2023	$0.55	$0.37	($0.18)	$0.92	$3.60 billion	$3.66 billion
Get the Latest News and Ratings for TEVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.
2/8/2023	Q4 2022	$0.64	$0.68	+$0.04	$2.46	$3.90 billion	$3.88 billion
11/3/2022	Q3 2022	$0.58	$0.56	($0.02)	$1.07	$3.86 billion	$3.60 billion
7/26/2022	Q2 2022	$0.55	$0.64	+$0.09	$1.49	$3.82 billion	$3.79 billion
5/3/2022	Q1 2022	$0.53	$0.53	-	$1.92	$3.75 billion	$3.66 billion
2/9/2022	Q4 2021	$0.70	$0.74	+$0.04	$1.62	$4.28 billion	$4.10 billion
10/27/2021	Q3 2021	$0.65	$0.59	($0.06)	$0.88	$4.05 billion	$3.89 billion
7/28/2021	Q2 2021	$0.55	$0.59	+$0.04	$0.95	$4.03 billion	$3.91 billion
4/28/2021	Q1 2021	$0.55	$0.63	+$0.08	$1.13	$4.04 billion	$3.98 billion
2/10/2021	Q4 2020	$0.63	$0.68	+$0.05	$1.14	$4.37 billion	$4.45 billion
11/5/2020	Q3 2020	$0.58	$0.58	-	$5.09	$4.09 billion	$4.00 billion
8/5/2020	Q2 2020	$0.53	$0.55	+$0.02	$0.91	$3.94 billion	$3.87 billion
5/7/2020	Q1 2020	$0.59	$0.76	+$0.17	$1.40	$4.15 billion	$4.36 billion
2/12/2020	Q4 2019	$0.61	$0.62	+$0.01	$1.12	$4.35 billion	$4.47 billion
11/7/2019	Q3 2019	$0.58	$0.56	($0.02)	$1.41	$4.25 billion	$4.26 billion

Teva Pharmaceutical Industries Earnings - Frequently Asked Questions

When is Teva Pharmaceutical Industries's earnings date?: Teva Pharmaceutical Industries has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates. Learn more on TEVA's earnings history.
What guidance has Teva Pharmaceutical Industries issued on next quarter's earnings?: Teva Pharmaceutical Industries issued an update on its FY 2024 earnings guidance on Wednesday, July, 31st. The company provided EPS guidance of 2.300-2.500 for the period, compared to the consensus estimate of 2.340. The company issued revenue guidance of $16.0 billion-$16.4 billion, compared to the consensus revenue estimate of $16.0 billion.
Did Teva Pharmaceutical Industries beat their earnings estimates last quarter?: In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.58 earnings per share (EPS) to beat the analysts' consensus estimate of $0.55 by $0.03. Learn more on analysts' earnings estimate vs. TEVA's actual earnings.
How much revenue does Teva Pharmaceutical Industries generate each year?: Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $15.85 billion.
How much profit does Teva Pharmaceutical Industries generate each year?: Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of -$559 million. TEVA has generated -$0.41 earnings per share over the last four quarters.
What is Teva Pharmaceutical Industries's price-to-earnings ratio?: Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 7.69. The price/earnings-to-growth ratio is 1.31.
What is Teva Pharmaceutical Industries's EPS forecast for next year?: Teva Pharmaceutical Industries's earnings are expected to grow from $2.35 per share to $2.63 per share in the next year, which is a 11.91% increase.